A Phase IIIb Multicentre Open-Label Study of Nilotinib in Adult Patients with Newly Diagnosed BCR-ABL Positive Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): A European Clinical Initiative with EUTOS Collaboration for Standardisation of Molecular Remission

Francis Joseph Giles

A Phase IIIb Multicentre Open-Label Study of Nilotinib in Adult Patients with Newly Diagnosed BCR-ABL Positive Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): A European Clinical Initiative with EUTOS Collaboration for Standardisation of Molecular Remission

Francis Joseph Giles

Medicine

Research output: Other contribution (Published) › Other contribution

Original language	English (Ireland)
Media of output	Meeting
Volume	118
Publication status	Published - 1 Nov 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@misc{8afa5a5633fc4f7ab9a9a5ae405a2e88,

title = "A Phase IIIb Multicentre Open-Label Study of Nilotinib in Adult Patients with Newly Diagnosed BCR-ABL Positive Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): A European Clinical Initiative with EUTOS Collaboration for Standardisation of Molecular Remission",

author = "Giles, \{Francis Joseph\}",

year = "2011",

month = nov,

day = "1",

language = "English (Ireland)",

volume = "118",

type = "Other",

}

TY - GEN

T1 - A Phase IIIb Multicentre Open-Label Study of Nilotinib in Adult Patients with Newly Diagnosed BCR-ABL Positive Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): A European Clinical Initiative with EUTOS Collaboration for Standardisation of Molecular Remission

AU - Giles, Francis Joseph

PY - 2011/11/1

Y1 - 2011/11/1

M3 - Other contribution

VL - 118

ER -